Professional Documents
Culture Documents
Antidiabetic Property of Spirulina: Preliminary Communication
Antidiabetic Property of Spirulina: Preliminary Communication
Tirupati, India
Preliminary Communication
Received: June 29, 2006
Accepted: January 5, 2007
SUMMARY
INTRODUCTION
Correspondence to: Dr. L. Anitha, Flat No. 403, Balaji Towers, Balaji
Colony, Tirupati 517 502, Andhra Pradesh, India
E-mail: anithalayam@rediffmail.com
29
Table 1. Blood glucose, plasma insulin, total hemoglobin, C-peptide and body weight in normal and experimental
animals
Body weight (g)
No.
1
Normal
Group
Diabetic control
Initial
196.337.42
197.6710.48
1922.85
Final
203.673.55
158.54.63
197.1711.89
196.513.12 209.676.65
Fasting blood
glucose
Plasma insulin
(mg/dL)
(/mL)
C-peptide
(ng/mL)
92.67a3.01
15.33a0.81
1.5a0.32
11.75a0.52
232.33b4.84
4.98b0.50
0.50b0.12
5.88b0.38
220.8b12.30
4.93b0.30
0.73b0.26
6.78c0.49
159.5c10.87
6.99c0.43
1.10c0.20
9.41d0.86
Hemoglobin
(g/dL)
202.6712.97
213.58.57
114.0a,d7.15
14.11d0.44
1.42d0.15
11.53e0.70
Diabetic + glibenclamide
600 g/kg
194.837.65
205.338.43
123.5d7.42
12.78e0.30
1.36e0.33
10.29d0.85
Values not sharing a common superscript letter differ significantly at p<0.05 (DMRT).
30
No. Group
Hexokinase
(unitsa/g
protein)
Glucose-6phosphatase
(unitsb/mg protein)
1
2
3
Normal
Diabetic control
Diabetic +
spirulina
15 mg/kg
148.76 6.09a
109.68 5.74b
130.72 7.44c
0.158 0.012a
0.232 0.013b
0.176 0.010a,c
Diabetic +
glibenclamide
600 g/kg
125.30 6.30c
0.190 0.007c
Values not sharing a common superscript letter differ significantly at p<0.05 (DMRT);
amoles of glucose phosphorylated/min; bmoles of Pi liberated/min
31
REFERENCES
1. Venkataraman LV. Spirulina: global reach of a health
care product. Souvenir, IFCON 98, 4th International
Food Convention, 1998;175.
32
33